BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
66 results:

  • 1. Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes.
    Bandidwattanawong C; Rattanaserikulchai P; Jetsadavanit N
    BMC Geriatr; 2023 Nov; 23(1):775. PubMed ID: 38012569
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage breast cancer.
    Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
    JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative Radiotherapy Does Not Change the Existing treatment Paradigm in Stage III breast cancer.
    He Y; Chen Q; Zhu F; Liu C; Shao Y; Liu H
    Oncology; 2024; 102(4):310-317. PubMed ID: 37748458
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line treatment of breast cancer by Race-Ethnicity: A SEER-Medicare Study.
    Herbach EL; Nash SH; Lizarraga IM; Carnahan RM; Wang K; Ogilvie AC; Curran M; Charlton ME
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1312-1322. PubMed ID: 37436422
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum cell division cycle 42 in advanced hepatocellular carcinoma patients: Linkage with clinical characteristics and immune checkpoint inhibitor-related treatment outcomes.
    Xu J; Shao R; Zhang X; Yao D; Han S
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102149. PubMed ID: 37247692
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. COVID-19 and breast cancer: Analysis of Surgical Management of a Large Referral Center during the 2020-2021 Pandemic Period.
    Borella F; Bertero L; Di Giovanni F; Witel G; Orlando G; Ricci AA; Pittaro A; Castellano I; Cassoni P
    Curr Oncol; 2023 May; 30(5):4767-4778. PubMed ID: 37232817
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of cancers During Chemoradiation Therapy: Real-World Study.
    Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
    JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
    Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
    Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study.
    Hassing CMS; Mejdahl MK; Lænkholm AV; Kroman N; Knoop AS; Tvedskov THF
    Breast Cancer Res Treat; 2022 Nov; 196(1):197-206. PubMed ID: 36076126
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.
    Usui Y; Iwasaki Y; Matsuo K; Endo M; Kamatani Y; Hirata M; Sugano K; Yoshida T; Matsuda K; Murakami Y; Maeda Y; Nakagawa H; Momozawa Y
    Cancer Sci; 2022 Nov; 113(11):3972-3979. PubMed ID: 36065483
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study.
    Rask G; Nazemroaya A; Jansson M; Wadsten C; Nilsson G; Blomqvist C; Holmberg L; Wärnberg F; Sund M
    Breast Cancer Res Treat; 2022 Oct; 195(3):367-377. PubMed ID: 35933487
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. breast cancer patients' most important quality of life themes for a radiotherapy decision aid.
    Roumen C; Hasannejadasl H; Swart R; Raphael D; Wee L; Sloep M; van den Bongard DHJG; Verkooijen H; Thijssen S; Velting M; Schuurman M; Russell NS; Fijten R; Boersma LJ
    Breast; 2022 Oct; 65():8-14. PubMed ID: 35728438
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Anatomical sites (Takasaki's segmentation) predicts the recurrence-free survival of hepatocellular carcinoma.
    Qin W; Wang L; Hu B; Tian H; Xiao C; Luo H; Yang Y
    BMC Surg; 2021 Jun; 21(1):278. PubMed ID: 34082743
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from breast and Castration-Resistant Prostate cancer.
    Tu MM; Clemons M; Stober C; Jeong A; Vandermeer L; Mates M; Blanchette P; Joy AA; Aseyev O; Pond G; Fergusson D; Ng TL; Thavorn K
    Curr Oncol; 2021 May; 28(3):1847-1856. PubMed ID: 34068083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin
    Schmidt M; KÜmmel S; Ruf-Doerdelmann A; Distelrath A; Wacker J; Schmatloch S; Busch-Liles S; LÜdtke-Heckenkamp K
    Anticancer Res; 2021 Jan; 41(1):485-496. PubMed ID: 33419847
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
    Polley MC; Leon-Ferre RA; Leung S; Cheng A; Gao D; Sinnwell J; Liu H; Hillman DW; Eyman-Casey A; Gilbert JA; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari K; Couch F; Carter JM; Visscher DW; Nielsen TO; Goetz MP
    Breast Cancer Res Treat; 2021 Feb; 185(3):557-566. PubMed ID: 33389409
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumescent technique versus electrocautery mastectomy: A randomized controlled trial.
    Lautrup MD; Thomsen JB; Christensen RD; Kjaer C
    Surg Oncol; 2020 Sep; 34():276-282. PubMed ID: 32891342
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The relationship between post-surgery infection and breast cancer recurrence.
    O'Connor RÍ; Kiely PA; Dunne CP
    J Hosp Infect; 2020 Nov; 106(3):522-535. PubMed ID: 32800825
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differences in Stage of cancer at Diagnosis, treatment, and Survival by Race and Ethnicity Among Leading cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.